AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

ARDX vs CYRX: stock comparison and AI forecast

Ardelyx, Inc. (ARDX) and Cryoport, Inc. (CYRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

ARDX Ardelyx, Inc.

Price
$2.99 -57.2% · 6M
Market Cap
$745M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

CYRX Cryoport, Inc.

Price
$16.05 +25.8% · 6M
Market Cap
$813M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

5075100125150
ARDX -57.2% CYRX +25.8%
ARDX · CYRX

Key facts

  • ARDX and CYRX have similar market capitalizations ($745M and $813M).
  • Over the last six months CYRX returned +25.8% and ARDX -57.2%.
  • ARDX turns -11.8% of its revenue into net income, against -19.5% for CYRX.
  • ARDX carries 2.58 times debt per unit of equity, against 0.55 times for CYRX.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricARDXCYRX
Market Cap$745M$813M
P/B Ratio4.54x1.68x
EPS$-0.26$-0.72
Book Value/Share$0.66$9.55
Revenue/Share$1.88$3.80
FCF/Share$-0.06$-0.37

Profitability & Margins

MetricARDXCYRX
ROE-33.8%-7.8%
ROA-9.4%-5.0%
ROIC-7.8%-6.9%
Gross Margin94.5%46.9%
Operating Margin-7.7%-18.8%
Net Margin-11.8%-19.5%
EBT Margin-11.8%-17.1%
Tax Rate-0.4%-5.9%

Financial Health

MetricARDXCYRX
Current Ratio3.45x2.04x
Quick Ratio2.22x1.94x
D/E Ratio2.58x0.55x
Financial Leverage3.58x1.55x
Interest Coverage0.8x-11.3x
Working Capital$314M$233M

Cash Flow

MetricARDXCYRX
Operating Cash Flow-$16M$11M
Free Cash Flow-$16M-$19M
Capital Spending-$440K-$30M
FCF/Sales-3.4%-9.8%
CapEx/Sales0.1%15.5%

Operational Efficiency

MetricARDXCYRX
Asset Turnover0.80x0.26x
Receivables Turnover5.0x5.3x
Inventory Turnover0.2x4.5x
Fixed Assets Turnover298.2x2.0x
Days Sales Outstanding73 days68 days
Days Inventory2215 days80 days
Payables Period473 days–
Cash Conversion Cycle1815 days–

Income Statement

MetricARDXCYRX
Total Revenue$468M$192M
Operating Income-$36M-$36M
Net Income-$55M-$38M
R&D Expense$94M$18M
SG&A Expense$384M$109M
Cost of Goods Sold$26M$102M

Dividend & Shareholder Information

MetricARDXCYRX
Shares Outstanding249M51M
Net Income Growth–-155.7%
EPS Growth–-170.6%
FAQ

ARDX vs CYRX: stock comparison and AI forecast

Which is bigger, ARDX or CYRX?

ARDX and CYRX have similar market capitalizations ($745M and $813M).

Which stock performed better over the last six months, ARDX or CYRX?

Over the last six months CYRX returned +25.8% and ARDX -57.2%.

Which one does Intratio's AI model rank higher, ARDX or CYRX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.